We are live on ! Find out more
SWAV icon

Shockwave Medical

Delisted

SWAV was delisted on the 30th of May, 2024.

240 hedge funds and large institutions have $6.11B invested in Shockwave Medical in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 82 increasing their positions, 71 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 33

55% more call options, than puts

Call options by funds: $73.4M | Put options by funds: $47.4M

15% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 71

11% more funds holding

Funds holding: 217 → 240 (+23)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less capital inflows, than outflows

Capital inflows: $453M | Capital outflows: $501M

1.54% less ownership

Funds ownership: 93.49% → 91.95% (-1.5%)

Holders
240
Holders Change
+23
Holders Change %
+10.6%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
56
Increased
82
Reduced
71
Closed
33
Calls
$73.4​M
Puts
$47.4​M
Net Calls
+$26​M
Net Calls Change
+$7.29​M

SWAV Hedge Fund Activity: Q2 2021 in Review

240 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical (SWAV) for Q2 2021, worth a combined $6.11B — up 44% from $4.24B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new SWAV positions and 33 closed out — a net gain of 23 holders — while 82 added to existing stakes and 71 trimmed.

The largest buyer was Invesco, adding an estimated $95.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $105M.

  • 240 institutional investors held Shockwave Medical (SWAV) as of Q2 2021, up from 217 in Q1 2021.
  • Funds reported $6.11B of Shockwave Medical stock for Q2 2021, up 44% quarter-over-quarter.
  • 56 funds opened new Shockwave Medical positions in Q2 2021 and 33 closed out, a net change of +23 holders.
  • The largest Shockwave Medical buyer in Q2 2021 was Invesco, an estimated $95.3M added.
  • The largest Shockwave Medical seller in Q2 2021 was T. Rowe Price Associates, an estimated $105M sold.

Based on aggregated 13F filings for Q2 2021.